FDA Expands Zepbound Label To Allow Use With Eli Lilly’s KwikPen
FDA updates Zepbound labeling, pairing tirzepatide with KwikPen for weight management and cardiovascular risk reduction, improving usability, adherence, and access for patients, clinicians, pharmacies, and healthcare systems.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.